1. Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world. (11th May 2022) Authors: Vodicka, Prokop; Benesova, Katerina; Janikova, Andrea; Prochazka, Vit; Belada, David; Mocikova, Heidi; Steinerova, Katerina; Duras, Juraj; Karban, Josef; Hanackova, Veronika; Sykorova, Alice; Obr, Ales; Trneny, Marek Journal: European journal of haematology Issue: Volume 109:Number 2(2022) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗